Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.18%
#3 CoW Protocol CoW Protocol +44.40%
#4 Glidr Glidr +36.87%
#5 Humanity Humanity +26.78%
#6 Walrus Walrus +24.24%
#7 Codatta Codatta +19.91%
#8 Enso Enso +18.69%
#9 Collector Crypt Collector Crypt +14.14%
#10 The Black Bull The Black Bull +13.35%
Coin of the day
EXOD EXOD
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
Hisse Senetlerindeki Sıralama #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
Hisse Fiyatı
$0.117
Son senkronizasyon: 2025-04-04
Piyasa Değeri
$2.45M
Değişim (1 gün)
-13.59%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Carmell Therapeutics Corporation (CTCX)

Kategori

Healthcare
Carmell Therapeutics Corporation (CTCX) için gelir
Jun 2026 itibarıyla gelir TTM: $1.69M
Carmell Therapeutics Corporation şirketinin en son finansal raporlarına göre, mevcut geliri (TTM) $1.69M'dir. 2023 yılında şirketin geliri 0.00 önceki yıla eşit 2022 yılındaki 0.00 gelirine göre. Gelir, bir şirketin mal veya hizmet satışından elde ettiği toplam tutardır. Kazançtan farklı olarak, hiçbir gider düşülmez.
Carmell Therapeutics Corporation için 2021 ile 2026 arasındaki gelir geçmişi
Her yılın sonunda gelir
Yıl Gelir Değiştir
2026 (TTM) $1.69M 3,251.88%
2024 $50.32K 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
Benzer şirketler veya rakiplerin geliri
Şirket Gelir Gelir Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 748,405.43%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 356,907.22%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B 599,377.10%
BE